A 6 month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Latin American men with erectile dysfunction

References

• National Institutes of Health. Erectile Dysfunction. National Institutes of Health website: http://kidney.niddk.nih.gov/KUDiseases/pubs/ED/index.aspx. Accessed 21 August 2012
   Google Scholar
• Torres LO, Ugarte y Romano F, Glina S. Erectile dysfunction epidemiology. Intl J Impot Res 2003;15(Suppl):S2-4
   PubMedGoogle Scholar
• Chen KK, Jiann BP, Lin JS, et al. Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: a randomized, double-blind, parallel, placebo-controlled clinical study. J Sex Med 2004;1:201-8
   PubMed Web of Science ®Google Scholar
• Rodrigues VL, Lledo GE, Rajmil O, et al. Preferencia de tadalafilo vs. sildenafilo en pacientes espanoles con disfuncion erectile: resultados procedentes de un studio multicentrico internacional. Actas Urol Esp 2006;30:67-79
   PubMedGoogle Scholar
• Aytac IA, McKinley J, Krane RJ, et al. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Intl 1999;84:50-6
   PubMed Web of Science ®Google Scholar
• Rosen RC, Fisher WA, Eardley I, et al. The multinational Men’s Attitudes to Life Events and Sexuality (MALES) study I: prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 2004;20:607-17
   PubMed Web of Science ®Google Scholar
• Moreira Jr ED, Abdo CHN, Torres EB, et al. Prevalence and correlates of erectile dysfunction: results of the Brazilian study of sexual behavior. Urology 2001;58:583-8
   PubMed Web of Science ®Google Scholar
• Ugarte-Romano F, Barroso-Aguirre J. Prevalencia de disfuncion erectile en Mexico y factores de riesgo asociados. Rev Mex Urol 2001;61:63-76
   Google Scholar
• Morillo LE, Diaz J, Estevez E, et al. Prevalence of erectile dysfunction in Colombia, Ecuador, and Venezuela: a population-based study (DENSA). Intl J Impot Res 2004;14(Suppl):S10-18
   Google Scholar
• Nolazco C, Bellora O, Lopez M, et al. Prevalence of sexual dysfunctions in Argentina. Intl J Impot Res 2004;16:69-72
   PubMed Web of Science ®Google Scholar
• Fink HA, MacDonald R, Rutks IR, et al. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 2002;162:1349-60
   PubMed Web of Science ®Google Scholar
• Hatzichristou D, Montorsi F, Buvat J, et al. The efficacy and safety of flexible-dose vardenafil (Levitra) in a broad population of European men. Eur Urol 2004;45:634-41
   PubMed Web of Science ®Google Scholar
• Skoumal R, Chen J, Kula K, et al. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction. Eur Urol 2004;46:362-9
   PubMed Web of Science ®Google Scholar
• Von Keitz A, Rajfer J, Segal S, et al. A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil. Eur Urol 2004;45:499-509
   PubMed Web of Science ®Google Scholar
• Rosen RC, Shabsigh R, Kuritzky L, et al. The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials. Curr Med Res Opin 2005;21:1701-9
   PubMed Web of Science ®Google Scholar
• Porst H, Rajfer J, Casabé A, et al. Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction. J Sex Med 2008;5:2160-9
   PubMed Web of Science ®Google Scholar
• Rubio-Aurioles E, Casabe A, Torres LO, et al. Efficacy and safety of tadalafil in the treatment of Latin American men with erectile dysfunction: results of integrated analyses. J Sex Med 2008;5:1965-76
   PubMed Web of Science ®Google Scholar
• Rubio-Aurioles E, Glina S, Abdo CHN, et al. Timing of dose relative to sexual intercourse attempt in previous sildenafil citrate users treated with tadalafil: a geographical comparison from a single-arm, open-label study. J Sex Med 2009;6:2836-50
   PubMed Web of Science ®Google Scholar
• Ricardi U, Gontero P, Ciammella P, et al. Efficacy and safety of tadalafil 20 mg on demand versus tadalafil 5 mg once-a-day in the treatment of post-radiotherapy erectile dysfunction in prostate cancer men: a randomized phase II trial. J Sex Med 2010;7:2851-9
   PubMed Web of Science ®Google Scholar
• Glina S, Toscano I, Gomatzky C, et al. Efficacy and tolerability of lodenafil carbonate for oral therapy in erectile dysfunction: a phase II clinical trial. J Sex Med 2009;6:553-7
   PubMed Web of Science ®Google Scholar
• Glina S, Fonseca GN, Bertero EB, et al. Efficacy and tolerability of lodenafil carbonate for oral therapy of erectile dysfunction: a phase III clinical trial. J Sex Med 2010;7:1928-36
   PubMed Web of Science ®Google Scholar
• Roumeguere T, Verheyden B, Arver S, et al. Therapeutic response after first month of tadalafil treatment predicts 12 months treatment continuation in patients with erectile dysfunction: results from the DETECT study. J Sex Med 2008;5:1708-19
   PubMed Web of Science ®Google Scholar
• Mulhall JP, McLaughlin TP, Harnett JP, et al. Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction. J Sex Med 2005;2:848-55
   PubMed Web of Science ®Google Scholar
• Hatzichristou D, Moysidis K, Apostolidis A, et al. Sildenafil failures may be due to inadequate patient instructions and follow-up: a study on 100 non-responders. Eur Urol 2005;47:518-23
   PubMed Web of Science ®Google Scholar
• Gruenwald I, Shenfeld O, Chen J, et al. Positive effect of counseling and dose adjustment in patients with erectile dysfunction who failed treatment with sildenafil. Eur Urol 2006;50:134-40
   PubMed Web of Science ®Google Scholar
• Hatzimouratidis K, Moysidis K, Bekos A, et al. Treatment strategy for ‘non-responders’ to tadalafil and vardenafil: a real-life-study. Eur Urol 2006;50:126-33
   PubMed Web of Science ®Google Scholar
• Klotz T, Mathers M, Klotz R, et al. Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra)? Intl J Impot Res 2005;17:2-4
   PubMed Web of Science ®Google Scholar
• Jiann BP, Yu C-C, Su C-C, et al. Compliance of sildenafil treatment for erectile dysfunction and factors affecting it. Intl J Impot Res 2006;18:146-9
   PubMed Web of Science ®Google Scholar
• Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-30
   PubMed Web of Science ®Google Scholar
• Althof SE, Corty EW, Levine SB, et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999;53:793-9
   PubMed Web of Science ®Google Scholar
• Cappelleri JC, Althof SE, Siegel RL, et al. Development and validation of the Self-Esteem and Relationship (SEAR) questionnaire in erectile dysfunction. Intl J Impot Res 2004;16:30-8
   PubMed Web of Science ®Google Scholar
• Mulhall JP, Goldstein I, Bushmakin AG, et al. Validation of the erection hardness score. J Sex Med 2007;4:1626-34
   PubMed Web of Science ®Google Scholar
• Leemis LM, Trivedi KS. A comparison of approximate interval estimators for the Bernoulli parameter. Amer Statist 1996;50:63-8
   Web of Science ®Google Scholar